Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
influenza A (H1N1) vaccine (Jiangsu CDC)
- Development stage
- Approved
- Lead developer
- Sinovac Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
This is an inactivated, split-virion, non-adjuvanted monovalent vaccine developed for the prevention of influenza A (H1N1) virus infection. Developed and evaluated by the Jiangsu Province Centers for Disease Control and Prevention, the vaccine contains 15 μg of hemagglutinin antigen. It was specifically studied in a prospective cohort and stratified controlled clinical trial involving pregnant women in China to assess safety and immunogenicity. The vaccine demonstrated a high seroconversion rate of 90.4% and was found to be safe for both the mothers and fetal growth, with a low adverse event rate. It was part of the public health response in China following the 2009 H1N1 pandemic.
- Other names
- split-virion, non-adjuvanted H1N1 vaccineinactivated H1N1 vaccine (Jiangsu CDC)influenza A (H1N1) vaccine-Jiangsu Province Centers for Disease Control and Prevention-influenza A (H1N1)
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on influenza A (H1N1) vaccine (Jiangsu CDC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on influenza A (H1N1) vaccine (Jiangsu CDC).